Transformative Approaches for Treating Autoimmune, Cancer, and Metabolic Diseases

The Therapeutics Stream at the PEGS Summit Boston brings together three dynamic programs showcasing the diversity of approaches driving the next generation of drug innovation. Biologics for Autoimmune Diseases will highlight emerging strategies across mainstream and niche indications, alongside cutting-edge modalities and translational tools that will offer durable treatment possibilities for patients. Advances in Immunotherapy explores emerging strategies to overcome immune escape, modulate the tumor microenvironment, and improve the safety, efficacy, and durability of immunotherapies for solid tumors and autoimmune disease. And the new Emerging Peptide Therapeutics track will spotlight the surge in peptide formats, delivery mechanism, and indications and feature advances in engineering, design, delivery, and therapeutic applications including half-life extended peptides and GLP-1 agonists. Together, these programs offer a comprehensive view of the therapeutic innovations poised to change patient care.

Conferences Include:

May 10-11

Emerging T Cell Engagers